Novo's Oral Wegovy Just Revealed a Surprising Weight-Loss Signal
Novo Nordisk (NVO, Financials) is getting another data point for its oral Wegovy program, with real-world study suggesting that those who recently gained weight can get higher weight-loss effects from the medication.The observational study involved more than 3,000 patients who had not previously us…